No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Brooks Laboratories Limited is a pharmaceutical enterprise engaged in the contractual manufacturing and distribution of medicinal products. The company serves both the Indian domestic market and international clients. Its comprehensive product portfolio includes carbapenem medications, various tablets, dry syrups, both liquid and powdered injectable solutions, and specialized eye and ear drops. Brooks Laboratories Limited was established in 2002 and is headquartered in Mumbai, India.
www.brookslabs.netNo one on the platform currently holds BROOKS.NS.
No tracked institution reports a position in BROOKS.NS as of their last filing.
No one on the platform has traded BROOKS.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BROOKS.NSBrooks Laboratories Limited | $61.23 | +0.34% | $1.8B | — |
| AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited | $101.72 | +1.78% | $2.9B | — |
| BAFNAPH.NSBafna Pharmaceuticals Limited | $311.00 | +0.65% | $7.4B | — |
| NECLIFE.BONectar Lifesciences Limited | $11.11 | +1.09% | $2.2B | — |
| NECLIFE.NSNectar Lifesciences Limited | $11.02 | +1.10% | $2.1B | — |
| TAKE.BOTAKE Solutions Limited | $16.91 | -4.95% | $2.5B | — |
| TAKE.NSTAKE Solutions Limited | $16.79 | -4.98% | $2.5B | — |
Source: Financial Modeling Prep · peers by sector/industry